Outcome of hospitalized MDR-TB patients: Israel 2000–2005

被引:0
|
作者
D. Bendayan
A. Hendler
V. Polansky
M. Weinberger
机构
[1] Shmuel Harofe Hospital,Pulmonary and Tuberculosis Department
[2] Tel Aviv University,Affiliated to the Sackler School of Medicine
[3] Assaf Harofe Hospital Medical Center,Infectious Diseases Unit
关键词
Tuberculosis; Former Soviet Union; Sputum Smear; Direct Observe Therapy; Line Drug;
D O I
暂无
中图分类号
学科分类号
摘要
MDR-TB has emerged in Israel following an immigrations wave from the Former Soviet Union (FSU) and Ethiopia. The purpose of this study was to outline characteristics and outcome of hospitalized MDR-TB patients. We retrospectively summarized charts of MDR-TB patients hospitalized in the national referral tuberculosis centers from January 2000 to December 2005, and followed them for 2 years. One hundred thirty-two patients were identified with a median age of 40 years and male predominance (77%). The majority of the patients were immigrants from FSU (83%) and Ethiopia (7.6%). They were characterized by alcohol (25.8%) and IV drug abuse (23.5%), presented with advanced disease manifested by hypoalbuminemia (50.8%) and smear positivity (70.5%). Cure was achieved in 50.3% and 30.4% died. Factors independently associated with death were patients’ age (OR = 1.036 for each year, 95%CI 1.0–1.1, p = 0.014), hypoalbuminemia (OR = 2.95, 95%CI 1.1–7.6, p = 0.025), smear positivity at diagnosis (OR = 3.7, 95%CI 1.2–11.4, p = 0.023), alcohol abuse (OR = 4.8, 95%CI 1.7–13.7, p = 0.004) and XDR-TB resistance pattern (OR 8.3, 95%CI 1.5–44.6, p = 0.014). This study brings out the poor prognosis of a highly vulnerable immigration population. Efforts should be focused on earlier diagnosis and treatment in a well controlled hospital environment and to professional support groups to attend to this population’s special needs.
引用
收藏
页码:375 / 379
页数:4
相关论文
共 50 条
  • [41] ECDC guidance on management of contacts of MDR-TB and XDR-TB patients
    Sandgren, Andreas
    van der Werf, Marieke
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [42] Cellular immune response in MDR-TB patients to different protein expression of MDR and susceptible Mycobacterium tuberculosis: Rv0147, a novel MDR-TB biomarker
    Alireza Hadizadeh Tasbiti
    Shamsi Yari
    Seyed Davar Siadat
    Payam Tabarsi
    Kayvan Saeedfar
    Fatemeh Yari
    [J]. Immunologic Research, 2018, 66 : 59 - 66
  • [43] Cellular immune response in MDR-TB patients to different protein expression of MDR and susceptible Mycobacterium tuberculosis: Rv0147, a novel MDR-TB biomarker
    Tasbiti, Alireza Hadizadeh
    Yari, Shamsi
    Siadat, Seyed Davar
    Tabarsi, Payam
    Saeedfar, Kayvan
    Yari, Fatemeh
    [J]. IMMUNOLOGIC RESEARCH, 2018, 66 (01) : 59 - 66
  • [44] Shorter drug regimens for MDR-TB
    不详
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2016, 94 (06) : 410 - 410
  • [45] Treatment of MDR-TB: is hepatotoxicity a problem?
    Loddenkemper, Robert
    Schaberg, Tom
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (05) : 571 - 571
  • [46] A Gut Wrenching Case Of Mdr-Tb
    Ahuja, S. B.
    Doo, K.
    Wu, B. G.
    Leibert, E.
    Condos, R.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [47] The dilemma of MDR-TB in the global era
    Farmer, P
    Bayona, J
    Becerra, M
    Furin, J
    Henry, C
    Hiatt, H
    Kim, JY
    Mitnick, C
    Nardell, E
    Shin, S
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 1998, 2 (11) : 869 - 876
  • [48] Treatment and management of MDR-TB in Latvia
    Leimane, Vaira
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2007, 85 (05) : 393 - 394
  • [49] MDR-TB and HIV: The perfect storm?
    Fierer, Joshua
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2006, 75 (06): : 1025 - 1026
  • [50] ICN offers nurses TB and MDR-TB resources
    不详
    [J]. INTERNATIONAL NURSING REVIEW, 2007, 54 (03) : 216 - 216